Wednesday 14 October 2026
Export ALHC’s income statement to Excel — free account
Alignment Healthcare, Inc.
ALHC Healthcare Healthcare Plans
Alignment Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.9 billion, up 46.1% from fiscal 2024. In the quarter to June 2026, revenue grew 31.6%, EPS grew 125.0%, free cash flow fell 229.5% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
8.30
0.21
+2.60%
Follow ALHC
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Piotroski F-Score |
6 | 5 | 2 | 4 | 3 | — | — | — |
Altman Z-Score |
5.52 | 3.59 | 2.95 | 3.81 | 4.83 | — | — | — |
P/S ratio |
0.99 | 0.79 | 0.87 | 1.47 | 2.07 | 2.75 | 2.75 | — |
P/FCF ratio |
34.54 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z″-Score (non-manufacturers) |
(0.35) | (2.32) | (3.47) | (1.24) | 0.09 | (1.50) | (2.75) | — |
Beneish M-Score |
(2.73) | (3.30) | (2.76) | (2.85) | (2.79) | (2.93) | — | — |
P/Operating CF |
(77.63) | (246.40) | (8.43) | (14.10) | (80.23) | (259.55) | (259.55) | — |
P/B ratio |
21.81 | 21.26 | 10.00 | 8.79 | 7.90 | 86.03 | 86.03 | — |
Price to Tangible BV |
27.41 | 34.86 | 13.40 | 10.57 | 8.92 | 0.00 | 0.00 | — |
EV/Sales |
0.92 | 0.74 | 0.78 | 1.29 | 1.80 | 2.68 | 2.68 | — |
EV/EBITDA |
79.46 | 0.00 | 0.00 | 0.00 | 0.00 | 207.45 | 207.45 | — |
EV/Operating CF |
25.95 | 57.49 | (24.06) | (40.84) | (26.68) | 339.94 | 339.94 | — |
EV/FCF |
32.07 | (301.30) | (14.96) | (26.81) | (21.64) | (319.41) | (319.41) | — |
Quick Ratio |
1.54 | 1.78 | 1.67 | 2.18 | 3.14 | 1.61 | 0.94 | — |
Current Ratio |
1.71 | 1.88 | 1.84 | 2.37 | 3.31 | 1.72 | 0.98 | — |
Net Debt/EBITDA |
(6.15) | 1.97 | 1.43 | 2.27 | 1.98 | (5.10) | (4.70) | — |
Debt/Assets |
30.32% | 41.10% | 27.34% | 25.38% | 23.87% | 42.59% | 71.32% | 0.00% |
Debt/Equity |
1.80 | 3.18 | 1.02 | 0.67 | 0.49 | 4.71 | (1.75) | — |
Asset Turnover |
4.27 | 3.94 | 2.98 | 2.27 | 2.41 | 3.61 | 7.83 | — |
Operating CF/Net income |
(193.27) | (0.27) | 0.40 | 0.30 | 0.40 | (0.33) | (0.21) | — |
Capex/Depreciation |
(0.86) | (1.61) | (2.00) | (1.23) | (1.00) | (0.88) | (0.55) | — |
Interest Coverage |
0.93 | (4.31) | (6.02) | (7.03) | (10.21) | (0.31) | (1.98) | — |
| (0.52%) | (98.86%) | (74.50%) | (54.84%) | (116.01%) | 95.33% | 186.00% | — | |
| (0.08%) | (18.64%) | (24.15%) | (23.65%) | (40.29%) | (8.62%) | (46.25%) | — | |
ROIC |
0.00% | 0.00% | (7,493.96%) | 0.00% | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
(0.16%) | (33.97%) | (54.33%) | (42.51%) | (46.95%) | (16.57%) | (182.30%) | — |
Average Days of Receivables |
23.41 | 20.78 | 23.97 | 23.64 | 18.29 | 15.27 | 17.18 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
11.23% | 13.74% | 16.86% | 20.61% | 24.92% | 16.30% | 14.55% | — |
Intangible Assets out of Total Assets |
0.03 | 0.05 | 0.07 | 0.06 | 0.06 | 0.10 | 0.18 | 0.00 |
Share Based Compensation of Revenue |
1.57% | 2.63% | 3.66% | 5.70% | 9.47% | 0.22% | 0.15% | — |
Graham Net Nets |
0.02 | (0.01) | 0.03 | 0.07 | 0.09 | (0.02) | (0.02) | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
0.00% | (6.04%) | (9.31%) | (7.06%) | (8.18%) | (0.87%) | (0.87%) | — |
Free Cash Flow Yield |
2.90% | (0.31%) | (6.02%) | (3.29%) | (4.02%) | (0.31%) | (0.31%) | — |
Revenue per Share |
19.94 | 14.17 | 9.79 | 7.91 | 6.79 | 6.31 | 5.57 | — |
Operating CF per Share |
0.71 | 0.18 | (0.32) | (0.25) | (0.46) | 0.05 | 0.07 | — |
Capex per Share |
(0.13) | (0.22) | (0.19) | (0.13) | (0.11) | (0.10) | (0.08) | — |
Free Cash Flow per Share |
0.57 | (0.03) | (0.51) | (0.38) | (0.56) | (0.05) | (0.01) | — |
Cash per Share |
3.05 | 2.47 | 1.71 | 2.26 | 2.71 | 1.36 | 0.64 | — |
Shareholders Equity per Share |
0.91 | 0.53 | 0.85 | 1.32 | 1.78 | 0.20 | (0.58) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
0.91 | 0.53 | 0.85 | 1.32 | 1.78 | 0.20 | (0.58) | — |
Free Cash Flow |
113.22 | (6.63) | (95.18) | (69.20) | (97.14) | (8.05) | (1.04) | — |
Working Capital |
394.71 | 309.79 | 220.52 | 314.59 | 385.61 | 111.22 | (2.90) | — |
Capital Expenditures |
(26.71) | (41.40) | (35.99) | (23.77) | (18.36) | (15.61) | (10.24) | — |
Net Current Asset Value |
65.07 | (19.47) | 49.73 | 149.99 | 228.02 | (43.21) | (144.80) | — |
EV/EBIT |
246.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | — |
Price to Operating Income |
265.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.48 | 0.38 | 0.35 | 0.52 | 0.60 | 0.65 | 0.68 | — |
Cash ROIC |
10.23% | (0.74%) | (14.90%) | (8.55%) | (10.52%) | (2.11%) | (0.71%) | — |
Accounts Receivable Turnover |
19.40 | 19.76 | 17.15 | 18.95 | 23.67 | 25.32 | 19.98 | — |
Accounts Payable Turnover |
8.44 | 8.90 | 7.52 | 7.23 | 7.65 | 6.45 | 5.38 | — |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
53.57 | 47.30 | 51.49 | 59.11 | 50.35 | 59.05 | 64.97 | — |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Receivables |
203.56 | 136.83 | 106.32 | 75.70 | 49.33 | 37.89 | 37.89 | — |
Average Payables |
409.88 | 270.41 | 215.67 | 172.87 | 135.80 | 123.01 | 123.01 | — |
Average Assets |
923.92 | 686.97 | 612.87 | 632.38 | 484.70 | 265.97 | 96.72 | — |
Average Common Equity |
140.12 | 129.51 | 198.69 | 272.68 | 168.33 | (24.05) | (24.05) | — |
Columns are period end dates